Effect of Hypercholesterolemia With or Without Hypertension on Coronary Artery Stenosis in Patients With Angina: a Retrospective Study
NCT ID: NCT04444024
Last Updated: 2020-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2020-09-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Correlation Between the Coronary Stenosis Degree With FFRCT and the Grade of Stable Angina Pectoris
NCT02802046
Correlation Between the Severity of Coronary Artery Disease and Peripheral Arterial Stiffness in Patients With Premature Coronary Heart Disease
NCT04578522
Carotid Atherosclerosis in Predicting Coronary Artery Disease
NCT06253962
The Association Between Central Aortic Blood Pressure Indices and Severity of Coronary Artery Disease
NCT02471768
Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
NCT07316452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators refer to the recent diagnostic guidelines for coronary heart disease angina pectoris at home and abroad. The diagnosis can be given if it meets any one or more of the following:
1. There was a clear history of old myocardial infarction.
2. Previous coronary angiography or coronary CTA examination showed that at least one major branch of coronary artery has a lumen diameter stenosis ≥50%.
3. Those with ST-segment depression or T-wave inversion on ECG after coronary revascularization.
The investigators will redefined hypertension as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg according to the recently published 2017 ACC/AHA guidelines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NTC/-HTN group
Patients with TC \< 5.18 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to normal TC/ none hypertension(NTC/-HTN) group.
No interventions assigned to this group
NTC/+HTN group
Patients with TC \< 5.18 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to normal TC/ hypertension(NTC/+HTN) group.
No interventions assigned to this group
BHTC/-HTN group
Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to borderline-high TC/ none hypertension (BHTC/-HTN) group.
No interventions assigned to this group
BHTC/+HTN group
Patients whose TC is 5.18 ≤ TC \< 6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg belong to borderline-high TC/ hypertension (BHTC/+HTN) group.
No interventions assigned to this group
HTC/-HTN group
Patients with TC ≥6.19 mmol/l, systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg belong to high TC/ none hypertension(HTC/-HTN) group.
No interventions assigned to this group
HTC/+HTN group
Patients with TC ≥6.19 mmol/l, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥ 80 mmHg belong to high TC/ hypertension(HTC/+HTN) group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Those who were hospitalized between September 1, 2014 and September 1, 2019.
3. Patients with Coronary heart disease angina pectoris and have undergone coronary angiography in the inpatient department of cardiovascular internal medicine.
4. The diagnosis of hypercholesterolemia, Coronary heart disease angina pectoris and hypertension is accorded with the diagnostic criteria.
Exclusion Criteria
2. Those with myocarditis, cardiomyopathy, acute myocardial infarction, third degree of heart failure, severe heart valve disease, major diseases such as malignant tumor and serious metabolic diseases, liver failure or renal failure.
3. Those with psychotic disorders, or cognitive dysfunction.
4. Those of childbearing age and have fertility requirements, or pregnant women or lactating women.
5. Those allergic to iodine contrast medium.
6. Those who are not suitable for the study, as judged by the researcher.
35 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chunquan Yu
researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020TJUTCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.